Department of Health and Human Services December 7, 2007 – Federal Register Recent Federal Regulation Documents
Results 1 - 6 of 6
Implantation or Injectable Dosage Form New Animal Drugs; Erythromycin
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Cross Vetpharm Group Ltd. The supplemental NADA provides for use of a 100 milligram per milliliter (mg/mL) strength erythromycin injectable solution in cattle for the treatment of bovine respiratory disease.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.